Luciferase News and Research

RSS
Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

SARS-CoV-2 shown to spread through cell-to-cell transmission

SARS-CoV-2 shown to spread through cell-to-cell transmission

SARS-CoV-2 Delta sublineage AY.4.2 shows no increase in cell entry or antibody evasion

SARS-CoV-2 Delta sublineage AY.4.2 shows no increase in cell entry or antibody evasion

Small molecule identified as a SARS-CoV-2 inhibitor

Small molecule identified as a SARS-CoV-2 inhibitor

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

Nanoengineers develop a new approach to effectively deliver mRNA into cells

Nanoengineers develop a new approach to effectively deliver mRNA into cells

Monitoring cellular metabolism for NAFLD/NASH liver disease research

Monitoring cellular metabolism for NAFLD/NASH liver disease research

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Rare disease diagnosis by 100,000 genomes pilot

Rare disease diagnosis by 100,000 genomes pilot

The autoantibody profile in COVID-19 patients with MIS-C

The autoantibody profile in COVID-19 patients with MIS-C

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

SARS-CoV-2 variants neutralized by camel nanobodies

SARS-CoV-2 variants neutralized by camel nanobodies

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

The challenges of exchanging buffer in gene therapy and vaccine preparation

The challenges of exchanging buffer in gene therapy and vaccine preparation

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings